Christine Silverstein, Director of Abeona Therapeutics Inc, sold 25,821 shares, now owning 62,063 shares. Abeona focuses on gene therapies for rare genetic diseases like EB-101 and ABO-102.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing